[1] |
王辉,俞云松,王明贵,等. 替加环素体外药敏试验操作规程专家共识[J]. 中华检验医学杂志,2013,36(7):584-587.
|
[2] |
杜小幸,王海萍,傅鹰,等. 不同药敏方法检测替加环素对鲍曼不动杆菌敏感性的比较[J]. 中华检验医学杂志,2013,36(7):598-603.
|
[3] |
POURNARAS S,KOUMAKI V,SPANAKIS N,et al.Current perspectives on tigecycline resistance in Enterobacteriaceae:susceptibility testing issues and mechanisms of resistance[J]. Int J Antimicrob Agents,2016,48(1):11-18.
|
[4] |
赵春江,陈宏斌,王辉,等. 2013年全国13所教学医院院内血流感染及院内获得性肺炎和院内获得性腹腔感染常见病原菌分布和耐药性研究[J]. 中华医学杂志,2015,95(22):1739-1746.
|
[5] |
胡付品,朱德妹,汪复,等. 2014年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志,2015,15(5):401-410.
|
[6] |
张冀霞,赵春江,刘文云,等. 替加环素对鲍曼不动杆菌和肺炎克雷伯菌体外抗菌活性检测的影响因素和方法学评估[J]. 中华检验医学杂志,2013,36(7):604-609.
|
[7] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility testing[S].M2-A10,CLSI,2009.
|
[8] |
Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically[S].M7-A8,CLSI,2009.
|
[9] |
王辉. 对《替加环素体外药敏试验操作规程专家共识》一文的更正[J]. 中华检验医学杂志,2015,38(8):569.
|
[10] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S25,CLSI,2015.
|
[11] |
李春辉. MDR、XDR、PDR多重耐药菌暂行标准定义——国际专家建议[J]. 中国感染控制杂志,2014,13(1):62-64.
|
[12] |
DENG M,ZHU M H,LI J J,et al.Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital[J]. Antimicrob Agents Chemother,2014,58(1):297-303.
|
[13] |
SPANU T,DE ANGELIS G,CIPRIANI M,et al.In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli[J]. Antimicrob Agents Chemother,2012 ,56(8):4516-4518.
|
[14] |
刘立荣,李向阳,瞿玲娜,等. 替加环素对不同耐药基因型耐碳青霉烯类肠杆菌科细菌的敏感性研究[J]. 检验医学,2016 ,31(5):383-386.
|